SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. 2000. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 275: 1522015225.
  • Bas E, Dinh CT, Garnham C, Polak M, Van De Water TR. 2012. Conservation of hearing and protection of hair cells in cochlear implant patients' with residual hearing. Anat Rec 00: 000000.
  • Batuman OA, Ferrero AP, Diaz A, Jimenez SA. 1991. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest 88: 15741580.
  • Bissonnette EY, Enciso JA, Befus AD. 1997. TGF-beta1 inhibits the release of histamine and tumor necrosis factor-alpha from mast cells through an autocrine pathway. Am J Respir Cell Mol Biol 16: 275282.
  • Blom IE, van Dijk AJ, Wieten L, Duran K, Ito Y, Kleij L, deNichilo M, Rabelink TJ, Weening JJ, Aten J, Goldschmeding R. 2001. In vitro evidence for differential involvement of CTGF, TGFb, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 16: 11391148.
  • Cunningham L, Tan J. 2011. Cell death in the inner ear. In: Reed JC, Green DR, editors. Apoptosis: physiology and pathology. Cambridge. p 182193.
  • Dinh CT, Haake S, Chen S, Hoang K, Nong E, Eshraghi AA, Balkany TJ, Van De Water TR. 2008. Dexamethasone protects organ of corti explants against tumor necrosis factor-alpha-induced loss of auditory hair cells and alters the expression levels of apoptosis-related genes. Neuroscience 157: 405413.
  • Dinh CT, Bas E, Chan SS, Dinh JN, Vu L, Van De Water TR. 2011. Dexamethasone treatment of tumor necrosis factor-alpha challenged organ of Corti explants activates nuclear factor kappa B signaling that induces changes in gene expression that favor hair cell survival. Neuroscience 188: 157167.
  • Gomes A, Fernandes E, Lima JLFC, Mira L, Luísa Corvo ML, 2008. Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr Med Chem 15: 15861605.
  • Goppelt-Struebe M, Wolter D, Resch K. 1989. Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase. Br J Pharmacol 98: 12871295.
  • Gouveris H, Schuler-Schmidt W, Mewes T, Mann W. 2011. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Otol Neurotol 32: 756760.
  • Haake SM, Dinh CT, Chen S, Eshraghi AA, Van De Water TR. 2009. Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Hear Res 255: 2232.
  • Haydont V, Mathé D, Bourgier C, Abdelali J, Aigueperse J, Bourhis J, Vozenin-Brotons MC. 2005. Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives. Radiother Oncol 76: 219225.
  • Hoang KN, Dinh CT, Bas E, Chen S, Eshraghi AA, Van De Water TR. 2009. Dexamethasone treatment of naïve organ of Corti explants alters the expression pattern of apoptosis-related genes. Brain Res 1301: 18.
  • Li J, Chen J, Kirsner R. 2007. Pathophysiology of acute wound healing. Clin Dermatol 25: 918.
  • Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. 2006. Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24: 99146.
  • Livak KJ and Schmittgen TD. 2001. Analysis of relative gene expression data using real time quantitative PCR and the 2(−ΔΔCT) method. Methods 25: 402408.
  • Lorito G, Hatzopoulos S, Laurell G, Campbell KC, Petruccelli J, Giordano P, Kochanek K, Sliwa L, Martini A, Skarzynski H. 2011. Dose-dependent protection on cisplatin-induced ototoxicity—an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model. Med Sci Monit 17: 179186.
  • Makishima T, Hochman L, Armstrong P, Rosenberger E, Ridley R, Woo M, Perachio A, Wood S. 2011. Inner ear dysfunction in caspase-3 deficient mice. BMC Neurosci 12: 102.
  • Namazi MR, Fallahzadeh MK, Schwartz RA. 2011. Strategies for prevention of scars: what can we learn from fetal skin? Int J Dermatol 50: 8593.
  • Nowotny M, Remus M, Kössl M, Gaese BH. 2011. Characterization of the perceived sound of trauma-induced tinnitus in gerbils. J Acoust Soc Am 130: 2827.
  • Park SK, Yang WS, Lee SK, Ahn H, Park JS, Hwang O, Lee JD. 2000. TGF-beta 1 down-regulates inflammatory cytokine-induced VCAM-1 expression in cultured human glomerular endothelial cells. Nephrol Dial Transplant 15: 596604.
  • Sly DJ, Hampson AJ, Minter RL, Heffer LF, Li J, Millard RE, Winata L, Niasari A, O'Leary SJ. 2011. Brain-derived neurotrophic factor modulates auditory function in the hearing cochlea. J Assoc Res Otolaryngol 1: 116.
  • Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, Finkel T. 1996. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 318: 379382.
  • Tandon A, Tovey JCK, Sharma A, Gupta R, Mohan RR. 2010. Role of transforming growth factor beta in corneal function, biology and pathology. Curr Mol Med 10: 565578.
  • Tsirogianni AK, Moutsopoulos NM, Moutsopoulos HM. 2006. Wound healing: immunological aspects. Injury Int J Care Injured 37: S5S12.
  • Vodovotz Y, Letterio JJ, Geiser AG, Chesler L, Roberts AB, Sparrow J. 1996. Control of nitric oxide production by endogenous TGF-β1 and systemic nitric oxide inretinal pigment epithelial cells and peritoneal macrophages. J Leukoc Biol 60: 261270.